Download PDF
Thromb Haemost 1973; 30(01): 012-017
DOI: 10.1055/s-0038-1649097
Original Article
Schattauer GmbH

A Controlled Trial of Aspirin in Childhood Glomerular Disorders

Carl W. Trygstad   *
1   Department of Pediatrics and Medicine, Indiana University-Purdue University Indianapolis, School of Medicine and Lilly Laboratory for Clinical Research
,
Nils U. Bang
1   Department of Pediatrics and Medicine, Indiana University-Purdue University Indianapolis, School of Medicine and Lilly Laboratory for Clinical Research
,
Robert O. Heldenreich
1   Department of Pediatrics and Medicine, Indiana University-Purdue University Indianapolis, School of Medicine and Lilly Laboratory for Clinical Research
,
Barbara M. Csiscko
1   Department of Pediatrics and Medicine, Indiana University-Purdue University Indianapolis, School of Medicine and Lilly Laboratory for Clinical Research
,
Bruce Rodda
1   Department of Pediatrics and Medicine, Indiana University-Purdue University Indianapolis, School of Medicine and Lilly Laboratory for Clinical Research
› Author Affiliations
Further Information

Publication History

Received for publication 12 June 1973

Accepted for publication 06 July 1973

Publication Date:
24 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

A controlled, prospective, double-blind study of the effect of aspirin on the clinical course and renal function of 36 children with proliferative glomerulonephritis or the nephrotic syndrome was undertaken. Despite unequivocal evidence of suppression of platelet aggregation with aspirin treatment, there were no statistically significant changes in the clinical course or any of the laboratory parameters denoting activity of the chronic glomerular renal disorder. It would appear, therefore, that additional factors besides local platelet aggregation must be involved in the perpetuation of chronic childhood renal disease.

* Reprint address: CWT, Department of Pediatrics, Harbor General Hospital, UCLA School of Medicine, 1000 West Carson Street, Torrance, California 90509.


 

  • References

  • 1 Abramowicz M, Barnett H. L, Edelman Jr. C. M, Grtjfer I, Kabazashi O, Arneil G. C, Barron B. A, Gordillo P. G, Hallman N, and Tiddens H. A. 1970; Controlled trial of azathioprine in children with nephrotic syndrome. Lancet 1: 959.
    PubMedSearch in Google Scholar
  • 2 Bang N. U, Trygstad C. W, Schroeder J. E, Heidenreich R. O, and Csiscko B. M. 1973; Enhanced platelet function in glomerular renal disease. Journal of Laboratory and Clinical Medicine 81: 651.
    PubMedSearch in Google Scholar
  • 3 Barratt T. M, and Soothill J. F. 1970; Controlled trial of cyclophosphamide in steroid sensitive relapsing nephrotic syndrome of childhood. Lancet 2: 479.
    PubMedSearch in Google Scholar
  • 4 Cade J. R, Dequesada A. M, Shires D. L, Levin D. M, Hackett R. L, Spooner G. R, Schein E. M, Pickering M. J, and Holcomb A. 1971; The effect of long term high dose heparin treatment on the course of chronic proliferative glomerulonephritis. Nephron 8: 67.
    CrossrefPubMedSearch in Google Scholar
  • 5 Duffy J.L, Cinque T, Grisham E, and Chung J. J. 1970; Intraglomerular fibrin, platelet aggregation and subendothelial deposits in lipoid nephrosis. Journal of Clinical Investigation 49: 251.
    CrossrefPubMedSearch in Google Scholar
  • 6 Henson P. M, and Cochrane C. G. 1971; Acute immune complex disease in rabbits. Journal of Experimental Medicine 133: 554.
    CrossrefPubMedSearch in Google Scholar
  • 7 Herdman R. L, Edson J. R, Pickering R. J, Fish A. J, Marker S, and Good R. A. 1970; Anticoagulation in renal disease in children. American Journal of Diseases of Children 119: 27.
    PubMedSearch in Google Scholar
  • 8 Kallen R. J, and Lewis E. J. 1973; “Immunosuppressive” treatment of “chronic glomerulonephritis.”. Journal of Pediatrics 82: 335.
    CrossrefPubMedSearch in Google Scholar
  • 9 Kincaid-Smith P. 1972; Coagulation and renal disease. Kidney International 2: 183.
    CrossrefPubMedSearch in Google Scholar
  • 10 Kincaid-Smith P, Saker B. M, and Fairley K. F. 1968; Anticoagulants in “irreversible” acute renal failure. Lancet 2: 1360.
    PubMedSearch in Google Scholar
  • 11 Stiehm E. R, and Trygstad C. W. 1969; Split products of fibrin in human renal disease. American Journal of Medicine 46: 786.
    PubMedSearch in Google Scholar
  • 12 Trygstad C. W, and Anand S. K. 1972; Glomerulonephritis in childhood. Current Problems in Pediatrics 2: 3.
    PubMedSearch in Google Scholar
  • 13 Vassalli P, and McCluskey R. T. 1964; The pathogenic role of the coagulation process in rabbit masugi nephritis. American Journal of Pathology 45: 653.
    PubMedSearch in Google Scholar